03/16/2022 | As 2022 takes shape, our industry finds itself at a point few of us expected: the start of a third year in this truly extraordinary era.
03/02/2022 | Winning all six core categories and three champion ratings validates us as a trusted partner.
02/23/2022 | John K. Moore from Vetter and Patrick Meyer from Rentschler Biopharma discuss the alliance between the two CDMOs.
02/18/2022 | In his recent interview, Thomas Otto shared his thoughts on how environmental responsibility shapes his vision for Vetter.
01/24/2022 | Peter Soelkner, one of our managing directors, recently sat down with Raman Sehgal of the “Molecule to Market” podcast to share his personal…
01/18/2022 | Vetter Development Service Rankweil has received the manufacturing authorization at this new clinical manufacturing site.
12/14/2021 | See where you need to focus if you’re planning to launch in an autoinjector, pen, or other patient-friendly delivery device.
12/02/2021 | We have been awarded the Frost & Sullivan’s 2021 Global Customer Value Leadership Award in the aseptic fill & finish market for providing high-value…
11/10/2021 | Peter Soelkner shares his insights on the impact of new trends and molecules, and how Vetter is adapting to stay ahead.
10/20/2021 | The Annex 1 of the EU GMP Guide "Manufacture of Sterile Medicinal Products" is considered the most important European regulatory standard for the…
10/05/2021 | Together our teams are breaking new ground in small batch filling. Learn more about this award-winning collaboration.
10/01/2021 | The field of drug development can be risky and a costly investment - mistakes can mean the success or failure of a compound or even a company.